Novartis and Malaria No More Campaign Provide Antimalarial Treatments in Zambia
Novartis delivers 2 million treatments of its pediatric antimalarial to Zambia in collaboration with Malaria No More's Power of One campaign.
Novartis reported that 2 million treatments of its pediatric antimalarial are arriving in Zambia due to collaboration with Malaria No More's Power of One campaign, a global digital fundraising operation. Zambia is the first beneficiary country of this campaign sponsored by Novartis. One million treatments of coartem dispersible have been funded through public donations and Novartis matched these with a further one million treatments.
The campaign, which launched to the public in September 2013, uses social, mobile, and e-commerce technologies, enabling the public to purchase treatments for children in Zambia. Novartis is supporting the campaign financially and has pledged to match up to one million treatments funded by the public every year through 2015. Since 2009, Novartis has delivered over 600 million treatments, of which more than 200 million were treatments developed specifically for children, without profit to malaria-endemic countries.
Source: Novartis
Texas' MD Anderson Cancer Center Creates New Cell Therapy Institute
November 11th 2024With the launch of the Institute for Cell Therapy Discovery and Innovation, the MD Anderson Cancer Center will bring together expertise in developing cell therapies for cancer, autoimmune diseases, and infections.
